Treatment
Intravenous clinical trials
We’re tracking 563 recruiting studies that include Intravenous, each written for real people, not researchers, below.
Recruiting studies
- NCT06784999RecruitingPhase 4
Pain relief after head and neck reconstructive surgery
This study compares two medicines, sufentanil and methadone, for pain control after head and neck surgery that uses a flap to rebuild tissue. The goal is to find which option works better and has fewer side effects.
Indianapolis, IndianaAges 18–80 - NCT06101082RecruitingPhase 1
Testing anti-HER2-CAR-T cells for advanced solid tumors
This study tests a new type of cell therapy called anti-HER2-CAR-T for people with advanced HER2-positive solid tumors (like breast, stomach, or colon cancer) whose cancer has not responded to other treatments. The therapy uses your own immune cells engineered to target and kill cancer cells.
Shenyang, LiaoningAges 18–70 - NCT07642193Recruiting
Nerve Blocks for Open Kidney Removal Surgery Pain
This trial compares two types of numbing injections (nerve blocks) given during kidney removal surgery to see which better controls pain afterward. Both are alternatives to general anesthesia alone.
CairoAges 18 years+ - NCT07648160Recruiting
Advanced Imaging Technology for Radiation Cancer Treatment
This study tests a new imaging camera that uses special dye to help doctors see tumors better during radiation therapy. It may help doctors target cancer more precisely while protecting healthy tissue.
Toronto, OntarioAges 18 years+ - NCT07513740Recruiting
Pain relief methods for hip fracture surgery
This trial compares two different nerve-block techniques (pain-relief injections) to see which one works better for patients having surgery to repair a broken hip. Both methods numb the area around the hip so you feel less pain during and after surgery.
Erzincan, Merkez/TürkiyeAges 18–75 - NCT07746973Enrolling by invitation
Magic show to reduce pain and fear during needle procedures
This study tests whether watching a magic show called 'Kuco' during a needle procedure (like getting blood drawn or an IV) helps children aged 5 to 8 feel less pain and fear. If your child needs a needle and can watch the show, they might be eligible to join.
Bingoel, BingölAges 5–8 - NCT07717684RecruitingPhase 4
Comparing remimazolam and propofol for sleep during gallbladder surgery
This study compares two medications used to put you to sleep for gallbladder removal surgery. It looks at how quickly you lose consciousness with remimazolam versus the standard drug propofol.
Aracaju, SergipeAges 18–49 - NCT07299006Recruiting
Study of a robot to help manage pain during IV placement in children
This trial tests whether a friendly robot named Paro can help reduce pain and anxiety in young children when they need an IV placed. If your child is between 1 and 7 years old and needs an IV, this study may help make the procedure less stressful.
BrestAges 1–7 - NCT07059845RecruitingPhase 2
Studying mirvetuximab combos for ovarian cancer
This trial tests multiple combinations of the drug mirvetuximab soravtansine with other treatments for people with ovarian cancer. It aims to see how well these combos work and what side effects they cause.
La Jolla, CaliforniaAges 18 years+ - NCT06571149RecruitingPhase 4
Blood thinners and clot-busting drugs for stroke
This trial tests whether giving a clot-dissolving medicine (alteplase or tenecteplase) is safe and effective for people who have had a stroke and are taking a blood thinner (DOAC) like apixaban or rivaroxaban. It aims to see if this treatment can still be given within a few hours of the stroke.
EisenstadtAges 18 years+ - NCT05669989Enrolling by invitationPhase 2
Continuing isatuximab treatment for multiple myeloma
This study allows people with multiple myeloma who are already benefiting from the drug isatuximab in an earlier clinical trial to keep receiving it after that trial ends. It is an extension study, meaning you can continue your treatment without interruption.
St Louis, MissouriAges 18 years+ - NCT07525206RecruitingPhase 3
New drug combination versus standard treatment for advanced colorectal cancer
This trial tests whether a new drug called telisotuzumab adizutecan, given with bevacizumab, works better than the current standard treatment for colorectal cancer that has spread and stopped responding to previous chemotherapy. The goal is to see if this new combination helps patients live longer.
East Brunswick, New JerseyAges 18 years+ - NCT07084012RecruitingPhase 2
Stem cell treatment for recent stroke
This trial tests whether a single infusion of umbilical cord stem cells can help people recover from a recent ischemic stroke (stroke caused by a clot). It is for patients who have had their stroke within the last 72 hours and have moderate to severe symptoms.
Beijing, Beijing MunicipalityAges 18–75 - NCT06714006RecruitingPhase 1
Testing safety of PYC-003 for ADPKD
This study is testing a new investigational medicine called PYC-003 for people with autosomal dominant polycystic kidney disease (ADPKD). It is one of the first studies in humans, so the main goal is to see if the medicine is safe and tolerable. The study is for people with a specific genetic cause (PKD1 mutation) and with certain kidney imaging types.
Southport, Gold CoastAges 18–65 - NCT07561125RecruitingPhase 2
IVIG for lung disease in very preterm infants
This trial tests whether giving intravenous immunoglobulin (IVIG) early after birth can help prevent or treat a serious lung condition called bronchopulmonary dysplasia (BPD) in babies born at 28 weeks or earlier. It may help reduce the need for breathing support and oxygen.
ShanghaiAges 1 day–2 months - NCT06568939RecruitingPhase 2
Study of telisotuzumab vedotin for non-squamous lung cancer
This trial tests a drug called telisotuzumab vedotin (ABBV-399) given through a vein to people with a specific type of advanced lung cancer (non-squamous non-small cell lung cancer) that has a high level of a protein called c-Met. The study aims to see how the drug affects the body and helps control the cancer.
Chandler, ArizonaAges 18 years+ - NCT07217899RecruitingPhase 2
Calcium to reduce bleeding after C-section
This trial tests if giving calcium through an IV before a C-section can help reduce blood loss in women at higher risk for heavy bleeding due to the uterus not contracting well.
Ann Arbor, MichiganAges 18 years+ - NCT07059000RecruitingPhase 3
Study of a drug for adults with chronic ITP
This trial tests an intravenous immunoglobulin (IVIg) treatment for adults who have had chronic immune thrombocytopenia (ITP) for more than a year. The goal is to see if this treatment can safely raise your platelet count.
Los Angeles, CaliforniaAges 18–70 - NCT07721571Recruiting
Pain control after kidney stone surgery via tube site injection
This trial tests whether injecting a numbing medicine into the tube site after kidney stone removal can reduce pain. If you are having this surgery, this approach might help you feel more comfortable afterward.
Çorum, ÇorumAges 18–75 - NCT07028177Recruiting
Etomidate dose for surgery in people with insomnia
This study looks at how much etomidate (a sleep-inducing medicine used during surgery) is needed for people with insomnia compared to those who sleep normally. It aims to help doctors give safer and more effective doses for patients with insomnia who need general anesthesia.
Beijing, Beijing MunicipalityAges 18–64 - NCT07717905RecruitingPhase 1/Phase 2
Testing BBT001 for chronic hives
This trial tests a new medicine called BBT001 for people with chronic spontaneous urticaria (long-lasting hives without a known cause). It aims to see if the drug is safe and helps reduce itching and hives.
Wuhu, AnhuiAges 18–75 - NCT06897007Recruiting
Ciprofol dosage in patients with insomnia under anesthesia
This study looks at how the sedative drug ciprofol works differently in people with insomnia compared to those who sleep well. It aims to help doctors give the right dose for your type of surgery.
Beijing, Beijing MunicipalityAges 18–64 - NCT07028190Recruiting
Rimazolen dose in insomnia patients under anesthesia
This trial looks at how much Rimazolen, a sleep medicine, is needed during surgery for people with insomnia compared to normal sleepers. It aims to find the right dose for better recovery.
Beijing, Beijing MunicipalityAges 18–64 - NCT06892522RecruitingPhase 1/Phase 2
T cell therapies for multiple myeloma
This trial tests new antibody treatments for multiple myeloma, given alone or with other drugs. It aims to see if they can control the disease and what side effects might occur.
Duarte, CaliforniaAges 18 years+
Common questions
- Are there clinical trials studying Intravenous?
- Yes. Clin2 currently lists 563 recruiting studies that include Intravenous, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Intravenous trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Intravenous an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Intravenous or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.